Ensuring patients with malignant bowel obstruction are central in research and clinical decisions

Affiliations

¹ Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK. Electronic address: jason.boland@hyms.ac.uk.
² Hull University Teaching Hospitals, Hull, UK.

Comment

Jason W Boland et al. Lancet Gastroenterol Hepatol. 2023 Oct.

. 2023 Oct;8(10):863-864.

doi: 10.1016/S2468-1253(23)00203-0. Epub 2023 Aug 1.

¹ Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK. Electronic address: jason.boland@hyms.ac.uk.
² Hull University Teaching Hospitals, Hull, UK.

No abstract available

Conflict of interest statement

We declare no competing interests.

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial.
Krouse RS, Anderson GL, Arnold KB, Thomson CA, Nfonsam VN, Al-Kasspooles MF, Walker JL, Sun V, Alvarez Secord A, Han ES, Leon-Takahashi AM, Isla-Ortiz D, Rodgers P, Hendren S, Sanchez Salcedo M, Laryea JA, Graybill WS, Flaherty DC, Mogal H, Miner TJ, Pimiento JM, Kitano M, Badgwell B, Whalen G, Lamont JP, Guevara OA, Senthil MS, Dewdney SB, Silberfein E, Wright JD, Friday B, Fahy B, Anantha Sathyanarayana S, O'Rourke M, Bakitas M, Sloan J, Grant M, Deutsch GB, Deneve JL. Krouse RS, et al. Lancet Gastroenterol Hepatol. 2023 Oct;8(10):908-918. doi: 10.1016/S2468-1253(23)00191-7. Epub 2023 Aug 1. Lancet Gastroenterol Hepatol. 2023. PMID: 37541263 Free PMC article. Clinical Trial.